Kidney protective mechanisms of SGLT2 inhibitors: evidence for a hemodynamic effect

被引:4
|
作者
Yau, Kevin [1 ,2 ]
Cherney, David Z. I. [1 ,2 ]
van Raalte, Daniel H. [3 ,4 ,5 ]
Wever, Britt E. [3 ,4 ]
机构
[1] Univ Hlth Network, Dept Med, Div Nephrol, Toronto, ON, Canada
[2] Univ Toronto, Dept Med, Toronto, ON, Canada
[3] Univ Amsterdam, Diabet Ctr, Med Ctr, Dept Internal Med, Amsterdam, Netherlands
[4] Vrije Univ Univ, Res Inst Amsterdam Cardiovasc Sci, Amsterdam, Netherlands
[5] Univ Amsterdam, Med Ctr, Dept Vasc Med, Amsterdam, Netherlands
基金
加拿大健康研究院;
关键词
GLUCOSE COTRANSPORTER-2 INHIBITION; GLOMERULAR-FILTRATION-RATE; TRIAL;
D O I
10.1016/j.kint.2024.03.019
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1168 / 1172
页数:5
相关论文
共 50 条
  • [31] SGLT2 INHIBITORS IN KIDNEY TRANSPLANTATION: A MULTICENTER STUDY
    Garcia Carro, Clara
    Bedia Raba, Andrea
    Banegas Deras, Eduardo J.
    Alberto Vigara, Luis
    Valero San Cecilio, Rosalia
    Cruzado Vega, Leonidas
    Gavela, Eva
    Gonzalez Garcia, M. Elena
    Perez-Flores, Isabel
    Sanchez-Bielsa, Francisco
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I884 - I884
  • [32] SGLT2 Inhibitors and Kidney Diseases: A Clinical Perspective
    Theofilis, Panagiotis
    Kalaitzidis, Rigas G.
    CURRENT MEDICINAL CHEMISTRY, 2023, 30 (23) : 2595 - 2603
  • [33] Effects of SGLT2 Inhibitors on Kidney and Cardiovascular Function
    Vallon, Volker
    Verma, Subodh
    ANNUAL REVIEW OF PHYSIOLOGY, VOL 83, 2021, 83 : 503 - 528
  • [34] SGLT2 inhibitors: diabetic kidney disease and beyond
    Staruschenko, Alexander
    Bhalla, Vivek
    Rangaswami, Janani
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2020, 319 (05) : F780 - F781
  • [35] SGLT2 INHIBITORS
    Brito, M.
    CLINICAL THERAPEUTICS, 2015, 37 (08) : E162 - E162
  • [36] Possible mechanisms of cardiovascular benefits of SGLT2 inhibitors
    Verges, B.
    ARCHIVES OF CARDIOVASCULAR DISEASES SUPPLEMENTS, 2019, 11 : S18 - S22
  • [37] SGLT2 inhibitors
    Dardi, I.
    Kouvatsos, T.
    Jabbour, S. A.
    BIOCHEMICAL PHARMACOLOGY, 2016, 101 : 27 - 39
  • [38] SGLT2 Inhibitors and the Mechanisms Involved in Weight Loss
    Feder D.
    de Fatima Veiga Gouveia M.R.
    Govato T.C.P.
    Nassis C.D.Z.
    Current Pharmacology Reports, 2020, 6 (6) : 346 - 353
  • [39] SGLT2 inhibitors
    Steyn, Lynda
    SA PHARMACEUTICAL JOURNAL, 2018, 85 (01) : 72 - 75
  • [40] Understanding the protective effects of SGLT2 inhibitors in type 2 diabetes patients with chronic kidney disease
    Scheen, Andre J.
    Delanaye, Pierre
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2022, 17 (01) : 35 - 46